-

Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia

IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that the company has been selected by a leading biologics company to perform procurement and construction management for a large-scale biologics drug substance manufacturing facility located in Scandinavia. Fluor will book the multi-hundred-million-dollar reimbursable contract value in the third quarter of 2022.

The facility will produce new capacity for advanced biologics that are used in a variety of treatments including vaccines, oncology and quality-of-life medicines. Fluor has performed the planning and enabling work for this project, and construction is now underway with the facility scheduled to be operational by 2025.

Fluor’s Advanced Technologies & Life Sciences business is leading the project including support from its Nordic Technology Hub in Copenhagen, Denmark.

About Fluor Corporation

Fluor Corporation (NYSE: FLR) is building a better future by applying world-class expertise to solve its clients’ greatest challenges. Fluor’s 41,000 employees provide professional and technical solutions that deliver safe, well-executed, capital-efficient projects to clients around the world. Fluor had revenue of $12.4 billion in 2021 and is ranked 259 among the Fortune 500 companies. With headquarters in Irving, Texas, Fluor has provided engineering, procurement and construction services for more than 110 years. For more information, please visit www.fluor.com or follow Fluor on Twitter, LinkedIn, Facebook and YouTube.

#atls

Contacts

Brian Mershon
Media Relations
469.398.7621

Jason Landkamer
Investor Relations
469.398.7222

Industry:

Fluor Corporation

NYSE:FLR
Release Versions
English

Contacts

Brian Mershon
Media Relations
469.398.7621

Jason Landkamer
Investor Relations
469.398.7222

More News From Fluor Corporation

Fluor Announces Appointment of Robert G. (Bob) Card to its Board of Directors

IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that Robert G. (Bob) Card, former President and CEO of SNC‑Lavalin and a seasoned global engineering and construction executive, has been elected to its Board of Directors effective March 4, 2026. Card will serve on the Board’s Audit Committee and Commercial Strategies and Operational Risk Committee. Card’s appointment brings the total number of Fluor Board members to 12 of whom 10 are independent. With more than thre...

Fluor Announces Retirement of Executive Chairman, David E. Constable, and Appointment of James T. (Jim) Hackett as Chairman of the Board

IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) today announced that David E. Constable, Executive Chairman, will step down from the Board of Directors following the Annual Shareholders Meeting on May 6, 2026. James T. (Jim) Hackett, the company’s Lead Independent Director, will assume the role of Chairman of the Board on May 5, 2026. Constable’s connection to Fluor spans 44 years. He began his career with the company in 1982, advancing through a series of global leadership roles...

Fluor Receives $1.35 Billion for 71 Million NuScale Shares; Launches Trading Program for Remaining 40 Million Shares

IRVING, Texas--(BUSINESS WIRE)--FLUOR RECEIVES $1.35 BILLION FOR 71 MILLION NUSCALE SHARES; LAUNCHES TRADING PROGRAM FOR REMAINING 40 MILLION SHARES...
Back to Newsroom